Sign In
Buy RDY
$11.85
+0.0200 (+0.169%)
At Close: Jul 31, 2026
HYDERABAD, India--(BUSINESS WIRE)-- #Aurigene--Aurigene inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India.
Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
09:53am, Tuesday, 28'th May 2024
HYDERABAD, India--(BUSINESS WIRE)---- $RDY #CEO--Dr. Reddy's Laboratories Ltd. today announced the appointment of Milan Kalawadia as Chief Executive Officer, North America.
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
01:21pm, Wednesday, 22'nd May 2024
Dr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop and commercialize the latter's biosimilar candidate, AVT03, to Prolia and Xgeva.
HYDERABAD, India & REYKJAVIK, Iceland--(BUSINESS WIRE)---- $RDY #Alvotech--Alvotech and Dr. Reddy's enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Proli
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
10:40am, Thursday, 09'th May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
10:05am, Wednesday, 08'th May 2024
Dr. Reddy's (RDY) posts better-than-expected fiscal fourth-quarter results on growth in global generics revenues in North America as well as Emerging Markets.
Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript
02:42pm, Tuesday, 07'th May 2024
Dr. Reddy's Laboratories Limited (NYSE:RDY ) Q4 2024 Earnings Conference Call May 7, 2024 10:00 AM ET Company Participants Richa Periwal - Head of Investor Relations GV Prasad - Co-Chairman and Managi
Dr. Reddy's Q4 & Full Year FY24 Financial Results
10:31am, Tuesday, 07'th May 2024
HYDERABAD, India--(BUSINESS WIRE)---- $RDY #DRREDDY--Dr. Reddy's Laboratories Ltd. today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2024.
Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.
08:00am, Friday, 03'rd May 2024
HYDERABAD, India--(BUSINESS WIRE)---- $RDY #Capsules--Dr. Reddy's Laboratories announces the launch of Doxycycline Capsules, 40 mg* in the U.S. market.
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
12:16pm, Thursday, 18'th Apr 2024
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, TEVA and VTRS.
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock
10:41am, Wednesday, 20'th Mar 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK
07:00am, Tuesday, 19'th Mar 2024
HYDERABAD, India--(BUSINESS WIRE)---- $RDY #Avastin--Dr. Reddy's Laboratories Ltd., a global pharmaceutical company, announced the launch of Versavo® (bevacizumab) in the United Kingdom (UK).
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 28'th Feb 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Doctor Reddy's (RDY) is a Strong Momentum Stock
10:56am, Friday, 23'rd Feb 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Doctor Reddy's (RDY) is a Top Growth Stock for the Long-Term
10:51am, Thursday, 22'nd Feb 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
